Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREPLAN: Bupivacaine and Methylprednisolone for Foot/Ankle Neuropathic Pain
NCT02680548Phase 1Completed
- Sponsor
- University Health Network
- Start
- Nov 2015
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, triple-blind trial of methylprednisolone in neuropathic pain, sponsored by University Health Network. Started Nov 2015; status: completed.
02
Drugs
methylprednisolone
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT02680548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02680548.